Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06152276Completed

SafeHeal Diverting Ileostomy Pivotal Study

Role: lead

NCT05180565Not ApplicableCompleted

Safe Anastomosis Feasibility Study

Role: lead

NCT07116668Not ApplicableEnrolling By Invitation

SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study

Role: lead

NCT05010850Not ApplicableTerminated

SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study

Role: lead

NCT06540807Not ApplicableActive Not Recruiting

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study

Role: lead

All 5 trials loaded